These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 16970772
1. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment. Chalasani R, Giblin M, Conway RM. Clin Exp Ophthalmol; 2006; 34(7):708-14. PubMed ID: 16970772 [Abstract] [Full Text] [Related]
2. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. Demirci H, McCormick SA, Finger PT. Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099 [Abstract] [Full Text] [Related]
3. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Finger PT, Czechonska G, Liarikos S. Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051 [Abstract] [Full Text] [Related]
4. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. Kurli M, Finger PT. Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485 [Abstract] [Full Text] [Related]
6. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C. Pe'er J, Frucht-Pery J. Am J Ophthalmol; 2005 Feb; 139(2):229-34. PubMed ID: 15733981 [Abstract] [Full Text] [Related]
9. [The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years]. Schmidt M, Maier M, Schmidt T, Klaehsen D, Merté RL. Klin Monbl Augenheilkd; 2001 Dec; 218(12):805-9. PubMed ID: 11805873 [Abstract] [Full Text] [Related]
10. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops]. Groh MJ, Holbach LM, Kühnel B, Conway RM, Naumann GO. Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895 [Abstract] [Full Text] [Related]
11. [Topical Mitomycin C as a therapy of conjunctival tumours]. Schallenberg M, Niederdräing N, Steuhl KP, Meller D. Ophthalmologe; 2008 Aug; 105(8):777-84. PubMed ID: 18618124 [Abstract] [Full Text] [Related]
12. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Finger PT, Sedeek RW, Chin KJ. Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257 [Abstract] [Full Text] [Related]
13. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis]. Werschnik C, Lommatzsch PK. Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467 [Abstract] [Full Text] [Related]
14. Evaluation of a short-term topical interferon α-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia. Garip A, Schaumberger MM, Wolf A, Herold TR, Miller CV, Klingenstein A, Schebitz-Walter K, Hintschich CR. Orbit; 2016 Jun; 35(1):29-34. PubMed ID: 26636727 [Abstract] [Full Text] [Related]
15. Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. Sacu S, Ségur-Eltz N, Horvat R, Lukas JR, Zehetmayer M. Am J Ophthalmol; 2003 Aug; 136(2):375-7. PubMed ID: 12888073 [Abstract] [Full Text] [Related]
16. Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy. Shields CL, Shields JA, Armstrong T. Am J Ophthalmol; 2001 Oct; 132(4):576-8. PubMed ID: 11589886 [Abstract] [Full Text] [Related]
18. Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma. Tunc M, Erbilen E. Am J Ophthalmol; 2006 Oct 22; 142(4):673-5. PubMed ID: 17011863 [Abstract] [Full Text] [Related]
19. Treatment of ocular surface squamous neoplasia with Mitomycin C. Gupta A, Muecke J. Br J Ophthalmol; 2010 May 22; 94(5):555-8. PubMed ID: 20447963 [Abstract] [Full Text] [Related]
20. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia. Lichtinger A, Pe'er J, Frucht-Pery J, Solomon A. Ophthalmology; 2010 Mar 22; 117(3):431-7. PubMed ID: 20060167 [Abstract] [Full Text] [Related] Page: [Next] [New Search]